DIALYSIS CORP OF AMERICA
DIALYSIS CORP OF AMERICA (DCAI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 95 transactions totaling $818.0K, demonstrating a bearish sentiment with -$714.6K in net insider flow. The most recent transaction on Jun 2, 2010 involved a transaction of 30,000 shares valued at $337.5K.
DCAI Insider Activity Summary
Who Is Buying DCAI Stock?
No significant insider buying has been recorded for DCAI in the recent period.
Who Is Selling DCAI Stock?
No significant insider selling has been recorded for DCAI in the recent period.
Is DIALYSIS CORP OF AMERICA Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DCAI is bearish with an Insider Alignment Score of 6/100 and a net flow of -$714.6K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
DCAI Frequently Asked Questions
Understanding DCAI Insider Activity
Insider trading at DIALYSIS CORP OF AMERICA (DCAI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading DCAI stock, having executed 95 transactions in the past 90 days. The most active insider is Thomas K. Langbein (Executive), who has made 18 transactions totaling $16.7M.
Related Tools
Track DIALYSIS CORP OF AMERICA Insider Activity
Get notified when executives and directors at DCAI file new Form 4 transactions